Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
Quick Stats
Feb 03, 202654.5
AI Score
HOLD0.86
Volume Ratio
Mar 05, 2026
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
PHAT Stock Summary
Last updated Feb 03, 2026
PHAT is currently trading at $13.81, positioned above its 200-day moving average of $10.92, indicating a long-term uptrend. The stock has a 52-week range of $2.21 to $18.31.
Technical Analysis: The 50-day moving average stands at $15.21, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.044, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.008, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PHAT at 54.5/100 with a HOLD recommendation.
PHAT (Phathom Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.044 |
| CMF (20) | 0.008 |
| ROC (10) | -2.403 |
| ADX (14) | 16.083 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.515 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -77.479 |
| MFI (14) | 40.821 |
PHAT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PHAT Price vs Max Options Open Interest
PHAT Max Change In Options Open Interest
PHAT Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Phathom Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PHAT Moving Averages Analysis
Phathom Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 03, 2026
PHAT (Phathom Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 13.83 |
| 20 | 14.59 |
| 30 | 15.4 |
| 50 | 15.21 |
| 100 | 14.0 |
| 200 | 10.92 |
PHAT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.1 billion |
| Earnings/Share ($) | -3.76 |
| Net Proft Margin (%) | -1.8653 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.3322 |
| EPS Estimate Next Year ($) | -0.1118 |
| WallStreet Target Price ($) | 22.9 |
| Most Recent Quarter |